Patient being consulted by doctor developing cell-based therapies
InGeneron's team of scientist are dedicated to evidence based clinical research

InGeneron Announces Encouraging Results from Emory University’s 480-Patient Phase III Knee Osteoarthritis Trial

Pipeline of regenerative cell therapies

InGeneron Publishes Overview on Current State and Potential of Regenerative Cell Therapy in Orthopedics

AMA to issue these new CPT codes

American Medical Association Issues New CPT® Category III Codes for InGeneron’s Cell Therapy for Rotator Cuff Tears

microscopic image of vaPS cells

InGeneron Publishes Significant Support for the Existence of Naturally Pluripotent Stem Cells in All Organs in the Adult Body

Human microscopic evidence of adult tendon regeneration following autologous stem cell treatment.

InGeneron Reports First-In-Human Microscopic Evidence of Adult Tendon Regeneration Following Autologous Stem Cell Treatment

isolated shoulder pain indication graphic

InGeneron Announces Publication of Rotator Cuff Feasibility Study

InGeneron Houston clinical-stage biotechnology company office logo

InGeneron Announces Publication of Preclinical Results for its Cell Therapy in Chronic Ischemic Heart Failure

Sanford Health Logo

InGeneron Extends Series D Financing to $43 Million to Bring Regenerative Cell Therapy into the Clinic

image of the regenerative cell extraction procedure

InGeneron Initiates Pivotal Study for its Clinical Lead Program in Rotator Cuff Tendinopathy

fresh autologus adipose derived regenerative cells

InGeneron Announces Publication of Results from First-in-Human Case Report of its Cell Therapy in Bone Regeneration

Pipeline of InGeneron's development of cell-based therapies to redefine the standard of care in orthopedics.

InGeneron Expands Development Pipeline with Two Osteoarthritis Programs

data analysis

InGeneron Reports Positive Top-Line Data From its Clinical Lead Program in Rotator Cuff Tendinopathy